Results 181 to 190 of about 19,810 (202)

Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Dolutegravir With Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial

Lancet, The, 2017
Paul E Sax, Anton Pozniak, Kirsten White
exaly  

Rifampicin Effect on Intracellular and Plasma Pharmacokinetics of Tenofovir Alafenamide

Journal of Antimicrobial Chemotherapy, 2019
Marta Boffito, Anton Pozniak, Charles Flexner   +2 more
exaly  

TENOFOVIR ALAFENAMIDE HEMIFUMARATE

2013
LIU DAZHAN, SHI BING, WANG FANG, YU RICHARD HUNG CHIU   +3 more
openaire   +9 more sources

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection: Rationale and Clinical Trial Evidence

Therapeutic Advances in Gastroenterology, 2018
Ivana Carey, Kosh Agarwal
exaly  

Emtricitabine/tenofovir alafenamide

Reactions Weekly, 2017
openaire   +1 more source

Gentamicin/tenofovir alafenamide

Reactions Weekly, 2020
openaire   +1 more source

Bictegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2023
openaire   +1 more source

Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Virus Infection

Expert Review of Clinical Pharmacology, 2017
Robert Gish, John D Ryan
exaly  

Tenofovir Alafenamide for Hepatitis B Virus Infection Including Switching Therapy From Tenofovir Disoproxil Fumarate

Journal of Gastroenterology and Hepatology (Australia), 2019
Mao Okada, Sakura Kirino, Namiki Izumi
exaly  

Tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source